96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial.
Farrell M, Shahbazi J, Chambers M, Byrne M, Gholami J, Zahra E, Grebely J, Lintzeris N, Larance B, Ali R, Nielsen S, Dunlop A, Dore GJ, McDonough M, Montebello M, Weiss R, Rodgers C, Cook J, Degenhardt L; CoLAB study team.
Farrell M, et al. Among authors: dore gj.
Int J Drug Policy. 2024 May;127:104390. doi: 10.1016/j.drugpo.2024.104390. Epub 2024 Mar 23.
Int J Drug Policy. 2024.
PMID: 38522175
Free article.